238 related articles for article (PubMed ID: 4621558)
1. Quide vs. Mellaril in chronic schizophrenic patients.
Gallant DM; Bishop MP
Curr Ther Res Clin Exp; 1972 Jan; 14(1):10-6. PubMed ID: 4621558
[No Abstract] [Full Text] [Related]
2. Butaperazine in chronic schizophrenic patients: a doubled-blinf study.
Brotman RK; Muzekari LH; Shanken PM
Curr Ther Res Clin Exp; 1969 Jan; 11(1):5-8. PubMed ID: 4387485
[No Abstract] [Full Text] [Related]
3. Clinical studies with propericiazine (R.P. 8909).
St Jean A; Sterlin C; Noe W; Ban TA
Dis Nerv Syst; 1967 Aug; 28(8):526-31. PubMed ID: 4383004
[No Abstract] [Full Text] [Related]
4. The treatment of lobotomized schizophrenic patients with butaperazine.
Holden JM; Itil TM; Keskiner A
Curr Ther Res Clin Exp; 1969 Jul; 11(7):418-28. PubMed ID: 4390417
[No Abstract] [Full Text] [Related]
5. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
Kiev A; Güclü B; Kulkarni AS
Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
[No Abstract] [Full Text] [Related]
6. Evaluation of a new antipsychotic agent. Piperacetazine (quide).
JAMA; 1971 Feb; 215(5):783-4. PubMed ID: 4395682
[No Abstract] [Full Text] [Related]
7. Piperacetazine in chronic mental patients: clinical observations and new urine color test.
Forrest FM; Forrest IS
Curr Ther Res Clin Exp; 1972 Nov; 14(11):689-95. PubMed ID: 4629106
[No Abstract] [Full Text] [Related]
8. A clinical study with propericiazine in chronic psychotic patients.
Deutsch M; Ananth JV; Ban TA
Curr Ther Res Clin Exp; 1971 Jun; 13(6):353-8. PubMed ID: 4397391
[No Abstract] [Full Text] [Related]
9. Drug responses of three hospital population samples participating in a collaborative study.
Crane GE; Krummholz W; Lichtigfeldt FJ; Salim T
Arzneimittelforschung; 1966 Feb; 16(2):290-3. PubMed ID: 4383294
[No Abstract] [Full Text] [Related]
10. Problems in the evaluation of the optimal dose of a phenothiazine (butaperazine).
Simpson GM; Amin M; Kunz-Bartholini E; Watts TP; Laska E
Dis Nerv Syst; 1968 Jul; 29(7):478-84. PubMed ID: 4386374
[No Abstract] [Full Text] [Related]
11. Piperacetazine (Quide): a controlled evaluation of the elixir in chronic schizophrenic patients.
Gallant DM; Bishop MP
Curr Ther Res Clin Exp; 1970 Jun; 12(6):387-9. PubMed ID: 4987346
[No Abstract] [Full Text] [Related]
12. SCH-12,041, a new anti-anxiety agent (quantitative pharmaco-electroencephalography and clinical trials).
Itil T; Gannon P; Cora R; Polvan N; Akpinar S; Elveris F; Eskazan E
Behav Neuropsychiatry; 1972; 4(4-5):15-24. PubMed ID: 4566673
[No Abstract] [Full Text] [Related]
13. Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
Jus A; Pineau R; Jus K; Villeneuve A; Gautier J; Pires P; Drolet A; Cote M; Villeneuve R
Curr Ther Res Clin Exp; 1974 Oct; 16(10):1041-58. PubMed ID: 4215617
[No Abstract] [Full Text] [Related]
14. Some effects of mesoridazine (TPS-23) on chronic psychiatric patients.
Douglas KW; Hindley JP; Kerin MT
Dis Nerv Syst; 1967 Feb; 28(2):113-7. PubMed ID: 6021590
[No Abstract] [Full Text] [Related]
15. [Experiences with depot form flupenthixol].
Bruck J; Guss H
Wien Med Wochenschr; 1971 Feb; 121(7):110-2. PubMed ID: 5545657
[No Abstract] [Full Text] [Related]
16. [Action of flupentixol decanoate in chronic psychoses of the schizophrenic type].
Evrard E; Heusghem C; Molders V; Plomteux G; Lebas A
Acta Psychiatr Belg; 1972 Sep; 72(5):573-94. PubMed ID: 4669430
[No Abstract] [Full Text] [Related]
17. [Comparative study of 2 drugs and a placebo in chronic schizophrenia].
Tetreault L
Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120
[No Abstract] [Full Text] [Related]
18. A controlled study of mesoridazine: an effective treatment for schizophrenia.
McIndoo MV
South Med J; 1971 May; 64(5):592-6. PubMed ID: 4929612
[No Abstract] [Full Text] [Related]
19. Butaperazine (Repoise).
Med Lett Drugs Ther; 1968 Nov; 10(22):89-90. PubMed ID: 4389275
[No Abstract] [Full Text] [Related]
20. A pilot study of pimozide in chronic schizophrenic patients.
Sugerman AA
Curr Ther Res Clin Exp; 1971 Nov; 13(11):706-13. PubMed ID: 5000718
[No Abstract] [Full Text] [Related]
[Next] [New Search]
